Cargando…
Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
We analyzed immune response to SARS-CoV-2 vaccination by measuring specific IgG titers and T-cell reactivity to different SARS-CoV-2 peptides in multiple sclerosis patients taking different disease-modifying treatments. Of the 88 patients included, 72 developed any kind of immune response after vacc...
Autores principales: | Meca-Lallana, Virginia, Esparcia-Pinedo, Laura, Aguirre, Clara, Díaz-Pérez, Carolina, Gutierrez-Cobos, Ainhoa, Sobrado, Mónica, Carabajal, Estefanía, Río, Beatriz del, Ropero, Noelia, Villagrasa, Ramón, Vivancos, José, Sanchez-Madrid, Francisco, Alfranca, Arantzazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898989/ https://www.ncbi.nlm.nih.gov/pubmed/38014396 http://dx.doi.org/10.1016/j.clicom.2023.02.001 |
Ejemplares similares
-
Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022) -
Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2023) -
Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
por: Esparcia-Pinedo, Laura, et al.
Publicado: (2022) -
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020) -
Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?
por: Aguirre, Clara, et al.
Publicado: (2020)